Login to Your Account

Deal or No Deal

Transaction Values Dipped Significantly in First Quarter

By Peter Winter

Monday, April 15, 2013

Like the number of biotech initial public offerings (IPOs) that are completed annually, another closely tracked statistic is the transactional value of the industry's mergers and acquisitions (M&As) and partnering deal flow. The number of deals concluded each year provides a measure of the vibrancy of the sector, its business strategies and technology aspirations.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription